Last Updated: March 8, 2016

Transcription

1 1 GreenScreen Version 1.3 Specified s Last Updated: March 8, 2016 Abbreviation CPA Type Name 1 AOEC Authoritative B Association of Asthmagens Occupational and Environmental Clinics (AOEC) Exposure Code 2 Boyes Neurotoxicants 3 EC CEPA Toxic Substances (Sched 1) 4 DOT (For reference only. This is not required for ) Screening B Screening B Authoritative A and B 5 EC CEPA DSL Screening A and B 6 US EPA EPCRA Extremely Hazardous Substances 7 US EPA IRIS Carcinogens Chemicals with Neurotoxicity-Based Occupational Exposure Standards (NIOSH/OSHA) Canadian Environmental Protection Act, 1999 (CEPA 1999): CEPA Toxic US Department of Transportation Hazardous Materials Regulations Canadian Categorization Decisions for Substances on the Domestic Substance (DSL). Authoritative B EPCRA Section 302 Extremely Hazardous Substances Authoritative A and B Integrated Risk Information System (IRIS) Database Results from four separate cancer guideline regimes: 1986, 1996, 1999, and Associated GreenScreen Hazard Endpoints Respiratory including Neurotoxicity, Neurotoxicity PBT in Multiple Endpoints, Irritation/, Flammability, Reactivity Persistence, Bioaccumulation and Multiple Endpoints for PBT and Human Health Carcinogenicity URL and/or Reference The main AOEC website is at the first link below. The current list of substances can be searched or listed from the webpage at the second link below. Neurotoxicology and Behavior chapter, William K. Boyes, Ph.D., et al.(eds.), in Patty s Industrial Hygiene and Toxicology, 2001 by John Wiley & Sons, Inc. Published Online: April 16, Chemicals listed in Table (Updated 2012 version does not contain Table 25.1) tox025/abstract A description of the CEPA Toxic Substances listing program appears at the first link. The current substance list is at the second link. Toxic.cfm asp?lang=en&n=0da2924d-1&wsdoc=4abeffc8-5bec- B57A-F4BF E434 DOT list is reference list only. It s not included in the or the Hazard Criteria. Canadian Environmental Protection Act, 1999 (CEPA), September Description and specific lists by type (first link). The DSL categorization search engine is at the second link. asp?lang=en&n=5f213fa8-1 asp?lang=en&n=5f213fa8-1&wsdoc=d031cb30-b31b- D54C-0E46-37E32D526A1F Link leads to the USEPA Consolidated of s, March GreenScreen utilizes only the EPCRA Section 302 Extremely Hazardous Substances. These are also listed in 40 CFR Part 355, Appendices A and B. Substance lists organized by cancer guideline (first link). Advanced search by substance (second link).

2 Version 1.3 specified s 2 Abbreviation CPA Type Name 8 US EPA Authoritative A EPA s Persistent Priority PBTs Bioaccumulative and Toxic (PPT) (PBT) Chemical Program, PBTs identified for the PBT Strategy, EPA Priority PBTs 9 EU REACH Annex XVII CMRs 10 EU Annex VI CMRs 11 EU Priority Endocrine Disrupters 12 EU GHS (H-Statements) Authoritative A Authoritative A Screening A and B Authoritative A and B European Union of Chemicals and their Harmonized (assigned) GHS Hazard Classifications R-Phrases. Based on the Dangerous Substances Directive (DSD). European Union of Chemicals and their Harmonized (assigned) GHS Hazard Classifications. European Union Priority of suspected endocrine disruptors. The EU country specific list is displayed separately as EU GHS (H-Statements). 13 EU ESIS PBT Authoritative A European Chemical Substances Information System (ESIS) PBT list 14 EU R-Phrases Authoritative A and B 15 EU SVHC Authorisation Authoritative A and B European Union of Chemicals and their Harmonized (assigned) GHS Hazard Classifications R-Phrases. Based on the Dangerous Substances Directive (DSD). European Union Substances of Very High Concern Subject to Authorization. Associated GreenScreen Hazard Endpoints PBT in Multiple Endpoints Carcinogenicity,,, Carcinogenicity,,, Endocrine Activity All endpoints, both individual and Multiple Endpoints PBT and combinations in the Multiple Endpoints All endpoints, both individual and Multiple Endpoints Carcinogenicity,, Endocrine Activity, and, and PBT Multiple Endpoints URL and/or Reference The EPA PBT Program is descibed at the first link. The second link contains a list of the Priority PBTs. ECHA CLP database: check box for harmonized classifications to avoid confusion with self-reported registrant data. Results listed in Table 3.2 (link below). ECHA CLP database: check box for harmonized classifications to avoid confusion with self-reported registrant data. Results listed in Table 3.1 (first link). Also available in the CLP regulation (second link). developed from four EU studies published between 1999 and Categorization results contained in 1) reports and 2) a consolidated Microsoft Access database at the link below. strategy/substances_en.htm#priority_list ECHA CLP database: check box for harmonized classifications to avoid confusion with self-reported registrant data. Results listed in Table 3.1 (first link). Also available in the CLP regulation (second link). European Union, European Chemicals Bureau, ESIS PBT Information System: s by CAS Number or Substance Name available from pull-down menu at link below (no longer available). ECHA CLP database: check box for harmonized classifications to avoid confusion with self-reported registrant data. Results listed in Table 3.2 (first link). Also available in the CLP regulation (second link). The of Substances Subject to Authorisation (Annex XIV of the REACH Regulation) is found at the first link. (Note: the Candidate is not presently included.) Additional information on authorisation can be found at the second link. authorisation

3 Version 1.3 specified s 3 Abbreviation CPA Type Name 16 G&L Screening B Grandjean & Landrigan, Neurotoxic of 201 Chemicals Chemicals Known to be Neurotoxic in Humans. 17 IARC Authoritative A and B 18 MAK Authoritative A and B International Agency for Research on Cancer (IARC), Substances Reviewed in IARC Monographs and Supplements. MAK Commission of Germany; Occupational Toxicants and MAK Values: Annual Thresholds and Classifications for the Workplace Associated GreenScreen Hazard Endpoints Neurotoxicity and (includes Neurotoxicity) Carcinogenicity Carcinogenicity, and (including Neurotoxicity), Skin and Respiratory URL and/or Reference Grandjean, P & PJ Landrigan, neurotoxicity of industrial chemicals, Lancet, v368: , 2006 (first link). Grandjean, P & PJ Landrigan, Neurobehavioural effects of developmental toxicity, The Lancet Neurology, V13: , published 2014 (second link). PIIS (06) /abstract s provided at the link below reference the relevant IARC monograph volume or supplement. Substances may be listed by CAS number, name or collectively as a substance group. The German Research Foundation s (DFG) Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area ( MAK Commission ) is at the first link. MAK Commission classification categories are available via PDFs at Wiley (second link, updated annually): senate/health_hazards/index.html US CDC Occupational Carcinogens Authoritative A National Institute of Occupational Safety and Health Carcinogen Carcinogenicity NIOSH s carcinogen policy is described at the first link below. The current occupational carcinogen list is at the second link US NIH & Monographs Authoritative A and B US National Institutes of Health, National Institute of Environmental Health Sciences, National Toxicology Program (NTP) Studies on and and The NIEHS Office of Health Assessment and Translation (OHAT) can be found at the first link. Reports and monographs from NTP studies (ongoing and completed) can be found at the second link. assoc/ohat/index.cfm 21 US NIH Report on Carcinogens Authoritative A US National Institutes of Health, National Institute of Environmental Health Sciences, National Toxicology Program (NTP), Report on Carcinogens (RoC) Carcinogenicity The Report on Carcinogens (RoC) is prepared by the National Toxicology Program (NTP) on behalf of the Secretary, Health and Human Services (description at the first link). The latest RoC edition is available at the second link US EPA Priority PBTs (NWMP) Authoritative A US Environmental Protection Agency (EPA), National Waste Minimization Program, Priority Chemicals PBT in Multiple Endpoints The National Waste Minimization Program Priority Chemicals can be found at the link below. Additional descriptive information is included in list footnotes.

4 Version 1.3 specified s 4 Abbreviation CPA Type Name 23 OR DEQ Screening A Oregon Department of Priority Environmental Quality Persistent (DEQ) Priority Persistent Pollutants Pollutant (P3), required in Oregon Senate Bill OSPAR Priority PBTs & EDs & equivalent concern 25 UNEP PIC Annex III 26 CA EPA Prop CA EPA Prop 65 (with qualifications)* 27 ChemSec SIN Authoritative A and Screening B Inclusion To Be Determined Authoritative A Authoritative B Screening A and B OSPAR Convention For the Protection of the Marine Environment of the North-East Atlantic, of Chemicals for Priority Action and of Substances of Possible Concern Prior Informed Consent (PIC) Convention, Annex III, from the 1998 Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade State of California Environmental Protection Agency, Office of Environmental Health Hazard Assessment (OEHHA) California Proposition 65 (Safe Drinking Water and Toxic Enforcement Act Of 1986) Chemicals Known to the State to Cause Cancer or State of California Environmental Protection Agency, Office of Environmental Health Hazard Assessment (OEHHA) California Proposition 65 (Safe Drinking Water and Toxic Enforcement Act Of 1986) Chemicals Known to the State to Cause Cancer or International Chemical Secretariat (ChemSec) Substitute it Now (SIN) ; SIN 2.1 available 2013 Associated GreenScreen Hazard Endpoints PBT in Multiple Endpoints PBT in Multiple Endpoints ; Endocrine Disruption Pending Carcinogenicity, and (including Neurotoxicity) Carcinogenicity, and (including Neurotoxicity) Endocrine Activity and Multiple Endpoints for CMR (Carcinogenicity, ; and ), PBT and vpvb URL and/or Reference The main website describing the list and process are at the first link. The second link contains a PDF list of P3 substances including technical listing criteria. P3LTechnicalDetailsFinal.pdf The first link contains an overview of the OSPAR hazardous substances program. The of Chemicals for Priority Action (as a Microsoft Word document) appears at the second link. A of Substances of Possible Concern (as a webpage) appears at the third link. overview priority-action possible-concern/list An overview of the Convention appears at the first link below. The list of current Annex III chemicals appears at the second link /language/en-US/Default.aspx AnnexIIIChemicals/tabid/1132/language/en-US/ Default.aspx Prop 65 descriptive information is at the first link below. The second link leads directly to a Microsoft Excel spreadsheet of the current list substances. P65list060514links.xls Prop 65 descriptive information is at the first link below. The second link leads directly to a Microsoft Excel spreadsheet of the current list substances. * With Qualification means Hazards may be formspecific or based on limited exposure pathways. P65list060514links.xls A description of ChemSec is available at the first link below. The current SIN can be searched or listed in full at the website at the second link below.

5 Version 1.3 specified s 5 Abbreviation CPA Type Name 28 UNEP Authoritative A United Nations Environment Stockholm Programme (UNEP), Conv Stockholm Convention Persistent Secretariat Stockholm Organic Convention on Persistent Pollutants Organic Pollutants (POPs) 29 TEDX Potential Endocrine Disruptor 30 US EPA Toxics Release Inventory PBTs 31 German FEA Substances Hazardous to Waters Screening B Authoritative A Screening B The Endocrine Disruptor Exchange (TEDX) of Potential Endocrine Disruptors US Environmental Protection Agency (EPA), Toxics Release Inventory (TRI) Program, TRI PBT Chemical German Federal Environment Agency, Administrative Regulation on the Classification of Substances hazardous to waters into Water Hazard Classes (Verwaltungsvorschrift wassergefahrdende Stoffe VwVwS) 32 WA DoE PBT Screening A State of Washington, Department of Ecology, Chapter WAC Persistent Bioaccumulative Toxins 33 Québec CSST WHMIS 1988 Authoritative B and Screening A and B Workplace Hazardous Materials Information System: Controlled Product as defined in Part IV of the Controlled Product Regulations (Canada) Associated GreenScreen Hazard Endpoints POP in PBT Multiple Endpoints Endocrine Activity PBT in Multiple Endpoints PBT in Multiple Endpoints PBT in Multiple Endpoints, Reactivity, Flammability and Multiple Endpoints URL and/or Reference The main Stockholm Convention website is at the first link below. The current POP chemicals are listed on the webpage at the second link below. ingofpops/tabid/2509/default.aspx The main TEDX website is at the first link below. The current list of potential endocrine disruptors can be searched or listed from the webpage at the second link below. tedx-list-of-potential-endocrine-disruptors/chemicalsearch The main EPA TRI website is at the first link below. The current TRI-PBTs are listed on the webpage at the second link. Information on the listing process and governing regulation is found at the first link below. A database of chemicals and classifications (Rigoletto) is at the second link. substances-hazardous-to-waters searchrequest.do?event=request The WA Department of Ecology PBT program website is at the first link below. The current PBTs are listed on the webpage at the second link. Description of the WHMIS is available at the first link below. The Quebec CSST site (second link) contains a list of controlled products, also available by CAS number and as a txt or PDF file. list-whmis-a.aspx

6 Version 1.3 specified s 6 Abbreviation CPA Type Name 34 GHS [COUNTRY]* 35 GHS Australia 36 GHS Indonesia Screening A and B Screening Screening Country-specific lists of chemicals classified using the Globally Harmonized System of Classification and Labeling. As of August 2014 the countries with published lists include Australia, the European Union, Indonesia, Japan, Korea, Malaysia, New Zealand, Taiwan and Thailand. Additional GHS country-specific classifications will be added as they become available. The EU country specific list is displayed separately as EU H-statements. Australia of Chemicals and their assigned GHS Classification. Indonesia of Chemicals and their assigned GHS Classification. 37 GHS Japan Screening Japanese of Chemicals and their assigned GHS Classification. 38 GHS Korea Screening Korea of Chemicals and their assigned GHS Classification. Associated GreenScreen Hazard Endpoints All endpoints including human health, ecotoxicity, fate and physical hazard endpoints. All human health, ecotoxicity, and physical hazard endpoints. All human health, ecotoxicity, and physical hazard endpoints. All human health, ecotoxicity, fate and physical hazard endpoints. All human health, ecotoxicity, and physical hazard endpoints. URL and/or Reference An OECD report on the public availability of national/ regional GHS classification from 2011 is at the first link below. The OECD website Public availability of national/ regional GHS classifications is at the second link pdf publicavailabilityofnationalregionalghsclassifications.htm Australia s hazardous substances home is available at the first link below. A substance search engine is available at the second link. A full updated list in PDFor Excel-format and a classification guidance manual are available at the third link. HazardousSubstance Consolidateds Indonesia s website on GHS implementation is available at the first link below (no English available). CIRS updates information on the progress of GHS implementation for many countries (available at the second link). peraturan/ Labelling.html Japan s GHS Classification Manual is available at the first link below. A substance search engine and webor Excel-based classification results are available at the second link. html#results The National Institute of Environmental Research (NIER) GHS website is at the first link (in Korean). The Korea list of classifications can be downloaded via the disk icon at the second link (also in Korean). jsp?seq=17

7 Version 1.3 specified s 7 Abbreviation CPA Type Name 39 GHS Screening Malaysia of Chemicals Malaysia and their assigned GHS Classification. 40 GHS New Zealand Screening New Zealand of Chemicals and their assigned GHS Classification. 41 GHS Taiwan Screening Taiwan of Chemicals and their assigned GHS Classification. 42 GHS Thailand Screening Thailand of Chemicals and their assigned GHS Classification. Associated GreenScreen Hazard Endpoints All human health, ecotoxicity, and physical hazard endpoints. All human health, ecotoxicity, and physical hazard endpoints. All human health, ecotoxicity, and physical hazard endpoints. All human health, ecotoxicity, and physical hazard endpoints. URL and/or Reference Malaysia s website on GHS implementation is available at the first link below. CIRS updates information on the progress of GHS implementation for many countries (available at the second link). cms.section.section_b252804d-c0a d5e4e71c Labelling.html The NZ Hazardous Substances and New Organisms (HSNO) program is at the first link below. The Chemical Classification and Information Database (CC) is available at the second link. A document describing the translation from HSNO to GHS classification is available at the third link. approvals/group-standards/pages/hsno_classification_ information.aspx HSNO-CC.aspx Taiwan s website on GHS implementation is available at the first link below (no English available). CIRS updates information on the progress of GHS implementation for many countries (available at the second link). Implementation.html Thailand s website on GHS implementation is available at the first link below (no English available). CIRS updates information on the progress of GHS implementation for many countries (available at the second link). Labelling.html Note: The GreenScreen Specified s includes all publically accessible published lists of chemicals classified using the Globally Harmonized System of Classification and Labeling and published by an authoritative governmental organization of a country. Country-specific GHS lists may be published by specifying GHS Categories or GHS H-statements for a group of chemicals. As of August 2014, the countries with published lists include Australia, the European Union, Indonesia, Japan, Korea, Malaysia, New Zealand, Taiwan, and Thailand.

8 Version 1.3 Definitions 8 1. Authoritative s Type Authoritative A Authoritative B Definition Authoritative lists are generated by recognized experts, often as part of a government regulatory process to identify chemicals and known associated hazards. These lists are considered to be of high reliability and should only be changed when new data or special circumstances clearly indicate that a new level-of-concern is warranted. Intervention of a Licensed Profiler or CPA s Toxicologist would be required to validate such a change. This category in the list translates directly to one of the following: 1) a single hazard classification for a single GreenScreen hazard endpoint, or 2) a single Benchmark. Categories that meet one or more of the following: 1) This category in the list incorporates a single GreenScreen hazard endpoint and does not translate directly to a single hazard classification or Benchmark; AND/OR 2) This category in the list refers to more than one GreenScreen hazard endpoint; AND/ OR 3) This category in the list specifies that the hazard is associated with a specific form of the substance or a specific exposure route. 2. Screening s Screening s result in a classification with a lower level of confidence because at least one of the following is true of the list. It was: a. developed using a less comprehensive review, b. compiled by an organization that is not considered to be authoritative, c. developed using predominantly or exclusively estimated data, or d. developed to identify chemicals for further review and/or testing. Screening A Screening B This category in the list translates directly to one of the following: 1) a single hazard classification for a single GreenScreen hazard endpoint, or 2) a single Benchmark. Categories that meet one or more of the following: 1) This category in the list incorporates a single GreenScreen hazard endpoint and does not translate directly to a single hazard classification or Benchmark; AND/OR 2) This category in the list refers to more than one GreenScreen hazard endpoint; AND/OR 3) This category in the list specifies that the hazard is associated with a specific form of the substance or a specific exposure route. Can You Modify Results? NO YES YES YES Level of Confidence High High Low Low

9 Version 1.3 Human Health Single Endpoints 9 GreenScreen Supporting Information GreenScreen 1 AOEC Asthmagens Asthmagen (Rr&Rs) irritant-induced & sensitizer-induced 2 AOEC Asthmagens Asthmagen (G) generally accepted 3 AOEC Asthmagens Asthmagen (Rr) irritant-induced 4 AOEC Asthmagens Asthmagen (Rs) sensitizer-induced 5 Boyes Neurotoxicants Neurotoxicity Green Screen Hazard Type A or B Hazard Range Respiratory Respiratory Respiratory Respiratory 6 Boyes Neurotoxicants Neurotoxic Neurotoxicity-Any Exposure 7 DOT (For reference only. This is not required for ) 8 DOT (For reference only. This is not required for ) 9 DOT (For reference only. This is not required for ) 10 DOT (For reference only. This is not required for ) 11 DOT (For reference only. This is not required for ) 12 DOT (For reference only. This is not required for ) 13 DOT (For reference only. This is not required for ) 14 DOT (For reference only. This is not required for ) Class 2.3 Group A Class 2.3 Group B Class 2.3 Group C Class 2.3 Group D Class 6.1 Group 1 Class 6.1 Group 2 Class 6.1 Group 3 Class 8 Acute Mammalian Acute Mammalian Acute Mammalian Acute Mammalian Acute Mammalian Acute Mammalian Acute Mammalian Skin Irritation/ Authoritative B H or M H or M (3) UNK Authoritative B H, M, or L UNK UNK Authoritative B H or M H or M (3) UNK Authoritative B H or M H or M (3) UNK Screening B H, M, or L UNK UNK Screening B vh, H, M, or L UNK UNK Authoritative B vh or H vh or H (2) UNK Authoritative B H or M H or M (3) UNK Authoritative B M or L M or L (4) UNK 15 EC CEPA DSL Bioaccumulative Bioaccumulation Screening A vh vh UNK 16 EC CEPA DSL it non-human (based Acute Aquatic Screening A vh vh UNK on eco T acute ) 17 EC CEPA DSL it non-human (based on eco T chronic) Chronic Aquatic Screening A vh vh UNK 18 EC CEPA DSL Persistent Persistence Screening B vh or H vh or H (2) UNK 19 US EPA EPCRA Extremely Extremely Hazardous Authoritative B vh or H vh or H (2) UNK Hazardous Substances Substances 20 US EPA IRIS Carcinogens (1986) Group A Human Carcinogen Carcinogenicity Notes: 1. For the purposes of scoring, the value was used. (1)vH; (2)H; (3)M; (4)L ; vh = very High; H = High; M = Moderate; L = Low; vl = very Low; UNK = Unknown (UNK can be used for both hazard classification and scores) 2. Report lowest score.

10 Version 1.3 Human Health Single Endpoints 10 GreenScreen Supporting Information 21 US EPA IRIS Carcinogens (1986) Group B1 Probable human Carcinogen 22 US EPA IRIS Carcinogens (1986) Group B2 Probable human Carcinogen 23 US EPA IRIS Carcinogens (1996) Known/likely human Carcinogen 24 US EPA IRIS Carcinogens (1999, 2005) Carcinogenic to humans 25 US EPA IRIS Carcinogens (1999, 2005) Likely to be Carcinogenic to humans 26 US EPA IRIS Carcinogens (1999) Suggestive evidence of Carcinogenicity 27 US EPA IRIS Carcinogens (1986) Group D Not classifiable as to human Carcinogenicity 28 US EPA IRIS Carcinogens (2005) Suggestive evidence of Carcinogenic potential 29 US EPA IRIS Carcinogens (1986) Group E Evidence of noncarcinogenicity for humans 30 US EPA IRIS Carcinogens (1999, 2005) Not likely to be Carcinogenic to humans 31 US EPA IRIS Carcinogens (1986) Group C Possible human Carcinogen 32 EU REACH Annex XVII CMRs 33 EU REACH Annex XVII CMRs 34 EU REACH Annex XVII CMRs 35 EU REACH Annex XVII CMRs 36 EU REACH Annex XVII CMRs Carcinogen Category 1 Substances known to be Carcinogenic to man Carcinogen Category 2 Substances which should be regarded as if they are Carcinogenic to man Mutagen Category 1 Substances known to be Mutagenic to man Mutagen Category 2 Substances which should be regarded as if they are Mutagenic to man Mutagen Category 3 Possible GreenScreen Green Screen Hazard Type A or B Hazard Range Carcinogenicity Carcinogenicity Carcinogenicity Carcinogenicity Carcinogenicity Carcinogenicity Authoritative B H, M or L UNK UNK Carcinogenicity Authoritative B H, M or L UNK UNK Carcinogenicity Authoritative B H, M or L UNK UNK Carcinogenicity Authoritative A L L UNK Carcinogenicity Authoritative A L L UNK Carcinogenicity Carcinogenicity Carcinogenicity

11 Version 1.3 Human Health Single Endpoints 11 GreenScreen Supporting Information 37 EU REACH Annex XVII CMRs Carcinogen Category 3 Possibly Carcinogenic to humans (listed as Carc. Cat. 3) 38 EU Annex VI CMRs Carcinogen Category 1A Known human Carcinogen based on human evidence 39 EU Annex VI CMRs Carcinogen Category 1B Presumed Carcinogen based on animal evidence 40 EU Annex VI CMRs Mutagen Category 1A GreenScreen Green Screen Hazard Type A or B Hazard Range Carcinogenicity Carcinogenicity Carcinogenicity 41 EU Annex VI CMRs Mutagen Category 1B 42 EU Annex VI CMRs Mutagen Category 2 43 EU Annex VI CMRs Carcinogen Category 2 Suspected human Carcinogen 44 EU Priority Endocrine Disrupters 45 EU Priority Endocrine Disrupters 46 EU Priority Endocrine Disrupters 47 EU Priority Endocrine Disrupters Category 3b (Substances with no or insufficient data gathered) Category 1 In vivo evidence of Endocrine Disruption Activity Category 2 In vitro evidence of biological activity related to Endocrine Disruption Category 3a (ED Studies available but no indication of ED effects) 48 EU GHS (H-Statements) H360D May damage the unborn child 49 EU GHS (H-Statements) H360FD May damage fertility. May damage the unborn child 50 EU GHS (H-Statements) H360Df May damage the unborn child. Suspected of damaging fertility 51 EU GHS (H-Statements) H360Fd May damage fertility. Suspected of damaging the unborn child 52 EU GHS (H-Statements) H361d Suspected of damaging the unborn child Carcinogenicity Endocrine Activity Screening B H, M, or L UNK UNK Endocrine Activity Screening B H or M H or M (3) P1 Endocrine Activity Screening B H or M H or M (3) P1 Endocrine Activity Screening A L L UNK

12 Version 1.3 Human Health Single Endpoints 12 GreenScreen Supporting Information 53 EU GHS (H-Statements) H361fd Suspected of damaging fertility. Suspected of damaging the unborn child 54 EU GHS (H-Statements) H350 May cause cancer 55 EU GHS (H-Statements) H350i May cause cancer by inhalation 56 EU GHS (H-Statements) H300 Fatal if swallowed 57 EU GHS (H-Statements) H301 Toxic if swallowed 58 EU GHS (H-Statements) H302 Harmful if swallowed 60 EU GHS (H-Statements) H310 Fatal in contact with skin 61 EU GHS (H-Statements) H311 Toxic in contact with skin 62 EU GHS (H-Statements) H312 Harmful in contact with skin 64 EU GHS (H-Statements) H314 Causes severe skin burns and eye damage 65 EU GHS (H-Statements) H315 Causes skin irritation GreenScreen Green Screen Hazard Type A or B Hazard Range Carcinogenicity Carcinogenicity Skin Irritation/ Skin Irritation/ 67 EU GHS (H-Statements) H317 May cause an allergic skin reaction 68 EU GHS (H-Statements) H318 Causes serious eye damage 69 EU GHS (H-Statements) H319 Causes serious eye irritation 70 EU GHS (H-Statements) H320 Causes eye irritation 71 EU GHS (H-Statements) H330 Fatal if inhaled 72 EU GHS (H-Statements) H331 Toxic if inhaled 73 EU GHS (H-Statements) H332 Harmful if inhaled 75 EU GHS (H-Statements) H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled 76 EU GHS (H-Statements) H335 May cause respiratory irritation 77 EU GHS (H-Statements) H336 May cause drowsiness or dizziness 78 EU GHS (H-Statements) H340 May cause genetic defects Skin Eye Irritation/ Eye Irritation/ Eye Irritation/ Respiratory Systemic / Neurotoxicity- Any Exposure Authoritative B H or M H or M (3) UNK Authoritative B H or M H or M (3) UNK Authoritative B M or L M or L (4) UNK

13 Version 1.3 Human Health Single Endpoints 13 GreenScreen Supporting Information 79 EU GHS (H-Statements) H341 Suspected of causing genetic defects 80 EU GHS (H-Statements) H370 Causes damage to organs 81 EU GHS (H-Statements) H371 May cause damage to organs 82 EU GHS (H-Statements) H372 Causes damage to organs through prolonged or repeated exposure 83 EU GHS (H-Statements) H373 May cause damage to organs through prolonged or repeated exposure 84 EU GHS (H-Statements) H400 Very toxic to aquatic life 87 EU GHS (H-Statements) H413 May cause long lasting harmful effects to aquatic life 88 EU GHS (H-Statements) H362 May cause harm to breast-fed children 89 EU GHS (H-Statements) H360F May damage fertility 90 EU GHS (H-Statements) H360FD May damage fertility. May damage the unborn child 91 EU GHS (H-Statements) H360Fd May damage fertility. Suspected of damaging the unborn child 92 EU GHS (H-Statements) H360Df May damage the unborn child. Suspected of damaging fertility 93 EU GHS (H-Statements) H361f Suspected of damaging fertility 94 EU GHS (H-Statements) H361fd Suspected of damaging fertility. Suspected of damaging the unborn child 95 EU GHS (H-Statements) H351 Suspected of causing cancer 96 EU R-Phrases R45 May cause cancer 97 EU R-Phrases R20 Harmful by Inhalation (gas or vapor or dust/mist) 98 EU R-Phrases R21 Harmful in Contact with Skin GreenScreen Green Screen Hazard Type A or B Hazard Range Systemic /Organ Effects Systemic /Organ Effects Systemic /Organ Effects (Repeated Exposure) Systemic /Organ Effects (Repeated Exposure) Acute Aquatic Chronic Aquatic Carcinogenicity Carcinogenicity Authoritative B H or M H or M (3) UNK Authoritative B H or M H or M (3) UNK

14 Version 1.3 Human Health Single Endpoints 14 GreenScreen Supporting Information GreenScreen 99 EU R-Phrases R22 Harmful if Swallowed 100 EU R-Phrases R23 Toxic by Inhalation (gas, vapour, dust/mist 101 EU R-Phrases R24 Toxic in Contact with Skin 102 EU R-Phrases R25 Toxic if Swallowed 103 EU R-Phrases R26 Very Toxic by Inhalation 104 EU R-Phrases R27 Very Toxic in Contact with Skin 105 EU R-Phrases R28 Very Toxic if Swallowed Green Screen Hazard Type A or B Hazard Range 106 EU R-Phrases R34 Causes burn Skin Irritation/ 107 EU R-Phrases R35 Causes severe burns 108 EU R-Phrases R36 Irritating to eyes 109 EU R-Phrases R37 Irritating to respiratory system 110 EU R-Phrases R38 Irritating to skin 111 EU R-Phrases R39 Danger of very serious irreversible effects 112 EU R-Phrases R39/23 Toxic: Danger of very serious irreversible effects through inhalation 113 EU R-Phrases R39/24 Toxic: Danger of very serious irreversible effects in contact with skin 114 EU R-Phrases R39/25 Toxic: Danger of very serious irreversible effects if swallowed 115 EU R-Phrases R39/26 Very Toxic: Danger of very serious irreversible effects through inhalation 116 EU R-Phrases R39/27 Very Toxic: Danger of very serious irreversible effects in contact with skin 117 EU R-Phrases R39/28 Very Toxic: Danger of very serious irreversible effects if swallowed Skin Irritation/ Eye Irritation/ Systemic /Organ Effects Skin Irritation/ Systemic / Systemic / Systemic / Systemic / Systemic / Systemic / Systemic / Authoritative B H or M H or M (3) UNK Authoritative B vh or H vh or H (2) UNK Authoritative B vh or H vh or H (2) UNK Authoritative B vh or H vh or H (2) UNK Authoritative B H or M H or M (3) UNK

15 Version 1.3 Human Health Single Endpoints 15 GreenScreen Supporting Information GreenScreen 118 EU R-Phrases R49 May cause cancer by inhalation 119 EU R-Phrases R41 Risk of serious damage to eyes 120 EU R-Phrases R42 May cause sensitization by inhalation 121 EU R-Phrases R43 May cause sensitization by skin contact 122 EU R-Phrases R46 May cause heritable genetic damage 123 EU R-Phrases R48/20 Harmful: Danger of Serious Damage to health by prolonged exposure through inhalation. 124 EU R-Phrases R48/21 Harmful: Danger of Serious Damage to health by prolonged exposure in contact with skin 125 EU R-Phrases R48/22 Harmful: Danger of Serious Damage to health by prolonged exposure if swallowed 126 EU R-Phrases R48/23 Toxic: Danger of Serious Damage to health by prolonged exposure through inhalation 127 EU R-Phrases R48/24 Toxic: Danger of Serious Damage to health by prolonged exposure in contact with skin 128 EU R-Phrases R48/25 Toxic: Danger of Serious Damage to health by prolonged exposure if swallowed 129 EU R-Phrases R50 Very Toxic to Aquatic Organisms EU R-Phrases R51/53 Toxic to Aquatic Organisms, May cause long-term adverse effects in the aquatic environment 130 EU R-Phrases R51 Toxic to Aquatic Organisms EU R-Phrases R52/53 Harmful to Aquatic Organisms, May cause long-term adverse effects in the aquatic environment Green Screen Hazard Type A or B Hazard Range Carcinogenicity Eye Irritation/ Respiratory Skin Systemic / (Repeated Exposure) Systemic / (Repeated Exposure) Systemic / (Repeated Exposure) Systemic / (Repeated Exposure) Systemic / (Repeated Exposure) Systemic / (Repeated Exposure) Acute Aquatic Acute Aquatic Acute Aquatic Acute Aquatic Authoritative B H or M H or M (3) UNK Authoritative B H or M H or M (3) UNK Authoritative B H or M H or M (3) UNK

16 Version 1.3 Human Health Single Endpoints 16 GreenScreen Supporting Information GreenScreen 131 EU R-Phrases R52 Harmful to Aquatic Organisms 132 EU R-Phrases R53 May cause long-term adverse effects in the aquatic environment Green Screen Hazard Type A or B Hazard Range Acute Aquatic Chronic Aquatic Authoritative B H or M H or M (3) UNK 133 EU R-Phrases R54 Toxic to flora Ecotoxicity Authoritative B vh, H, M UNK UNK 134 EU R-Phrases R55 Toxic to fauna Ecotoxicity Authoritative B vh, H, M UNK UNK 135 EU R-Phrases R56 Toxic to soil organisms Ecotoxicity Authoritative B vh, H, M UNK UNK 136 EU R-Phrases R57 Toxic to soil organisms 137 EU R-Phrases R60 May impair fertility 138 EU R-Phrases R61 May cause harm to the unborn child 139 EU R-Phrases R62 Possible risk of impaired fertility 140 EU R-Phrases R63 Possible risk of harm to the unborn child 141 EU R-Phrases R67 Vapors may cause drowsiness and dizziness 142 EU R-Phrases R64 May cause harm to breastfed babies 143 EU R-Phrases R68 May cause irreversible effects Ecotoxicity Authoritative B vh, H, M UNK UNK Neurotoxicity- Any Exposure Authoritative B M or L M or L (4) UNK 144 EU R-Phrases R68/20 Harmful: Possible risk of irreversible effects through inhalation 145 EU R-Phrases R68/21 Harmful: Possible risk of irreversible effects in contact with skin 146 EU R-Phrases R68/22 Harmful: Possible risk of irreversible effects if swallowed 147 EU R-Phrases R40 Limited Evidence of Carcinogenic Effects 148 EU SVHC Authorisation 149 EU SVHC Authorisation 150 EU SVHC Authorisation 151 G&L Neurotoxic Chemicals Carcinogenic Banned unless Authorised Mutagenic Banned unless Authorised Equivalent Concern Candidate Neurotoxicant Systemic /Organ Effects Systemic /Organ Effects Systemic /Organ Effects Carcinogenicity Carcinogenicity Endocrine Activity Screening B H or M H or M (3) P1

17 Version 1.3 Human Health Single Endpoints 17 GreenScreen Supporting Information GreenScreen 152 G&L Neurotoxic Chemicals Neurotoxic 153 IARC Group 1 Agent is Carcinogenic to humans 154 IARC Group 2a Agent is probably Carcinogenic to humans 155 IARC Group 3 Agent is not classifiable as to its carcinogenicity to humans 156 IARC Group 4 Agent is probably not carcinogenic to humans Green Screen Hazard Type A or B Hazard Range Neurotoxicity- Any Exposure Screening B vh, H, or M UNK UNK Carcinogenicity Carcinogenicity Carcinogenicity Authoritative B H, M or L UNK UNK Carcinogenicity Authoritative A L L UNK 157 IARC Group 2b Possibly Carcinogenicity carcinogenic to humans 158 MAK Carcinogen Group 1 Carcinogenicity Substances that cause cancer in man 159 MAK Carcinogen Group 2 Carcinogenicity Considered to be carcinogenic for man 160 MAK Germ Cell Mutagen 1 Authoritative B H or M H or M (3) P1 161 MAK Germ Cell Mutagen MAK Germ Cell Mutagen 3a 163 MAK Germ Cell Mutagen 3b 164 MAK Germ Cell Mutagen MAK Pregnancy Risk Group A 166 MAK Pregnancy Risk Group B 167 MAK Pregnancy Risk Group C 168 MAK Pregnancy Risk Group D 169 MAK Sensitizing Substance Sa Danger of airway sensitization 170 MAK Sensitizing Substance Sh Danger of skin sensitization Respiratory Skin Authoritative B H or M H or M (3) P1 Authoritative B H or M H or M (3) P1 Authoritative B H, M, or L UNK UNK Authoritative B H, M, or L UNK UNK Authoritative B H or M H or M (3) P1 Authoritative B H or M H or M (3) P1 Authoritative B M or L M or L (4) UNK Authoritative B H, M, or L UNK UNK

18 Version 1.3 Human Health Single Endpoints 18 GreenScreen Supporting Information 171 MAK Carcinogen Group 3A (or 3B) Evidence of carcinogenic effects but not sufficient to establish MAK/BAT value (classify) 172 MAK Carcinogen Group 4 Non-genotoxic carcinogen with low risk under MAK/BAT levels 173 MAK Carcinogen Group 5 Genotoxic carcinogen with very slight risk under MAK/BAT levels 174 US CDC Occupational Carcinogens 175 US NIH & Monographs 176 US NIH & Monographs 177 US NIH & Monographs 178 US NIH & Monographs 179 US NIH & Monographs 180 US NIH & Monographs 181 US NIH & Monographs 182 US NIH & Monographs 183 US NIH & Monographs 184 US NIH & Monographs 185 US NIH & Monographs 186 US NIH & Monographs Occupational Carcinogen Clear Evidence of Adverse Effects Clear Evidence of Adverse Effects Clear Evidence of no Adverse Effects Clear Evidence of no Adverse Effects Limited Evidence of Adverse Effects Limited Evidence of Adverse Effects Limited Evidence of no Adverse Effects Limited Evidence of no Adverse Effects Some Evidence of Adverse Effects Some Evidence of Adverse Effects Some Evidence of no Adverse Effects Some Evidence of no Adverse Effects GreenScreen Green Screen Hazard Type A or B Hazard Range Carcinogenicity Carcinogenicity Carcinogenicity Carcinogenicity Authoritative A L L UNK Authoritative A L L UNK Authoritative B H or M H or M (3) P1 Authoritative B H or M H or M (3) P1 Authoritative B M or L M or L (4) UNK Authoritative B M or L M or L (4) UNK Authoritative B H or M H or M (3) P1 Authoritative B H or M H or M (3) P1 Authoritative B M or L M or L (4) UNK Authoritative B M or L M or L (4) UNK

19 Version 1.3 Human Health Single Endpoints 19 GreenScreen Supporting Information GreenScreen 187 US NIH & Monographs 188 US NIH & Monographs 189 US NIH Report on Carcinogens 190 US NIH Report on Carcinogens 191 OSPAR Priority PBTs & EDs & equivalent concern CA EPA Prop 65 (with qualifications)* CA EPA Prop 65 (with qualifications)* CA EPA Prop 65 (with qualifications)* CA EPA Prop 65 (with qualifications)* Green Screen Hazard Type A or B Hazard Range Insufficient Evidence Authoritative B H, M, or L UNK UNK for a Conclusion Insufficient Evidence Authoritative B H, M, or L UNK UNK for a Conclusion Known to be a Carcinogenicity human Carcinogen Reasonably Anticipated to be Human Carcinogen Carcinogenicity Endocrine Distruptor Endocrine Activity Screening B H or M H or M (3) P1 Carcinogen specific to chemical form or exposure route toxicity toxicity Male toxicity Female Carcinogenicity Authoritative B H or M H or M P1 Authoritative B H or M H or M P1 Authoritative B H or M H or M P1 Authoritative B H or M H or M P1 192 CA EPA Prop 65 Carcinogen Carcinogenicity 193 CA EPA Prop 65 toxicity 194 CA EPA Prop 65 toxicity Male 195 CA EPA Prop 65 toxicity Female 196 ChemSec SIN Endocrine Disruption Endocrine Activity Screening B H or M H or M (3) P1 197 TEDX Potential Endocrine Potential Endocrine Endocrine Activity Screening B H or M H or M (3) P1 Disruptors Disruptor 198 Québec CSST WHMIS Québec CSST WHMIS 1988 Class D1A Very toxic material causing immediate and serious toxic effects Class D1B Toxic material causing immediate and serious toxic effects Acute Mammalian Acute Mammalian Screening B vh or H vh or H (2) UNK Screening B vh, H or M UNK UNK 200 GHS-[COUNTRY] Category 1A (Known) Carcinogenicity Screening A H H P1 201 GHS-[COUNTRY] Category 1B Carcinogenicity Screening A H H P1 (Presumed) 202 GHS-[COUNTRY] Category 2 (Suspected) 203 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 204 GHS-[COUNTRY] Category 1A (Known) 205 GHS-[COUNTRY] Category 1B (Presumed) Carcinogenicity Screening A M M UNK Carcinogenicity Screening A L L UNK Screening A H H P1 Screening A H H P1

20 Version 1.3 Human Health Single Endpoints 20 GreenScreen Supporting Information GreenScreen 206 GHS-[COUNTRY] Category 2 (Suspected) 207 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 208 GHS-[COUNTRY] Category 1A (Known) 209 GHS-[COUNTRY] Category 1B (Presumed) 210 GHS-[COUNTRY] Category 2 (Suspected) 211 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 212 GHS-[COUNTRY] Category 1A (Known) 213 GHS-[COUNTRY] Category 1B (Presumed) 214 GHS-[COUNTRY] Category 2 (Suspected) 215 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Green Screen Hazard Type A or B Hazard Range 216 GHS-[COUNTRY] Category GHS-[COUNTRY] Category GHS-[COUNTRY] Category GHS-[COUNTRY] Category GHS-[COUNTRY] Category GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 222 GHS-[COUNTRY] Category 1 Systemic / 223 GHS-[COUNTRY] Category 2 Systemic / 224 GHS-[COUNTRY] Category 3 Systemic / 225 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Systemic / 226 GHS-[COUNTRY] Category 1 Systemic / (Repeated Exposure) Screening A M M UNK Screening A L L UNK Screening A H H P1 Screening A H H P1 Screening A M M UNK Screening A L L UNK Screening A H H P1 Screening A H H P1 Screening A M M UNK Screening A L L UNK Screening A vh vh UNK Screening A vh vh UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A L L UNK Screening A vh vh UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A H H UNK

21 Version 1.3 Human Health Single Endpoints 21 GreenScreen Supporting Information GreenScreen 227 GHS-[COUNTRY] Category 2 Systemic / (Repeated Exposure) 228 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Green Screen Hazard Type A or B Hazard Range Systemic / (Repeated Exposure) 229 GHS-[COUNTRY] Category 1 Neurotoxicity- Single Exposure 230 GHS-[COUNTRY] Category 2 Neurotoxicity- Single Exposure 231 GHS-[COUNTRY] Category 3 Neurotoxicity- Single Exposure 232 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Neurotoxicity- Single Exposure 233 GHS-[COUNTRY] Category 1 Neurotoxicity Repeated Exposure 234 GHS-[COUNTRY] Category 2 Neurotoxicity Repeated Exposure 235 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 236 GHS-[COUNTRY] Category 1A (High Frequency of Occurrence) 237 GHS-[COUNTRY] Category 1B (Low to Moderate Frequency of Occurrence) 238 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 239 GHS-[COUNTRY] Category 1A (High Frequency of Occurrence) 240 GHS-[COUNTRY] Category 1B (Low to Moderate Frequency of Occurrence) 241 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) 242 GHS-[COUNTRY] Category 1 (Corrosive) 243 GHS-[COUNTRY] Category 2 (Irritant) 244 GHS-[COUNTRY] Category 3 (Mild irritant) 245 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Neurotoxicity Repeated Exposure Respiratory Respiratory Respiratory Skin Skin Skin Skin Irritation/ Skin Irritation/ Skin Irritation/ Skin Irritation/ Screening A M M UNK Screening A L L UNK Screening A vh vh UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A vh vh UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK

22 Version 1.3 Human Health Single Endpoints 22 GreenScreen Supporting Information GreenScreen 246 GHS-[COUNTRY] Category 1 (Irreversible) 247 GHS-[COUNTRY] Category 2A (Irritating) 248 GHS-[COUNTRY] Category 2B (Mildly irritating) 249 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Green Screen Hazard Type A or B Hazard Range Eye Irritation/ Eye Irritation/ Eye Irritation/ Eye Irritation/ 250 GHS-[COUNTRY] Category 1 Acute Aquatic 251 GHS-[COUNTRY] Category 2 Acute Aquatic 252 GHS-[COUNTRY] Category 3 Acute Aquatic 253 GHS-[COUNTRY] Not Classified (i.e. positively determined to be negative) Acute Aquatic 254 GHS-[COUNTRY] Category 4 Chronic Aquatic Screening A vh vh UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A vh vh UNK Screening A H H UNK Screening A M M UNK Screening A L L UNK Screening A M M UNK

23 Version 1.3 Multiple Endponts 23 GreenScreen Supporting Information GreenScreen Multiple GreenScreen Hazard Type A or B Hazard Range Screening B U Mult* UNK 1 Québec CSST WHMIS 1988 Class D2A Very toxic material causing other toxic effects and Class D2B Toxic material causing other toxic effects 2 EC CEPA DSL Inherently Toxic to Humans (it human) 3 EC CEPA Toxic Substances (Sched 1) CEPA Toxic 4 EC CEPA DSL Persistent, Bioaccumulative and inherently Toxic (PBiTE) to the Environment (based on aquatic organisms) 5 EC CEPA DSL Persistent, Bioaccumulative and inherently Toxic (PBiTH) to humans 6 US EPA Priority PBTs (NWMP) 7 OR DEQ Priority Persistent Pollutants 8 UNEP Stockholm Conv Persistent Organic Pollutants Priority PBT Priority Persistent Pollutant Tier 1 and Tier 2 (Legacy Persistent Pollutants) Priority POP One or more of the following Chronic Human Health Effects: Carcinogenicity,,,, Skin, Respiratory, Systemic /, Eye Irritation, Skin Irritation. One or more of the following Human Health Effects: Carcinogenicity,,,, Acute Mammalian, System /. One or more of the following: Human Health Effects, Ecotoxicity, and/or Fate endpoints. PBT [Persistence, Bioaccumulation, and any of the following: Acute Aquatic, Chronic Aquatic, Carcinogenicity, Mutagenicity,,, Systemic /- Repeated Exposure. PBT [Persistence, Bioaccumulation and Human (Human Health Effects)] PBT [Persistence, Bioaccumulation and any of the following: Ecotox and/or Human (Human Health Effects)] PBT [Persistence, Bioaccumulation and any of the following: Ecotox and/or Human (Human Health Effects)] PBT [Persistence, Bioaccumulation and any of the following: Ecotoxicity and/or Human (Human Health Effects)] 9 WA DoE PBT PBT PBT [Persistence, Bioaccumulation and any of the following: Ecotoxicity and/or Human (Human Health Effects)] 10 US EPA Priority PBTs (PPT) PBT PBT [Persistence, Bioaccumulation and any of the following: Ecotoxicity, Carcinogenicity, Mutagenicity,,, Neurotoxicity, Other chronic effects, or effects from site releases] 11 EU ESIS PBT PBT PBT [Persistence, Bioaccumulation and any of the following: Ecotoxicity and/or Human (Human Health Effects)] Screening B U Mult* UNK Screening B U Mult* UNK Screening A U Mult* P1 Screening A U Mult* P1 Authoritative A U Mult* 1 Screening A U Mult* P1 Authoritative A U Mult* 1 Screening A U Mult* P1 Authoritative A U Mult* 1 Authoritative A U Mult* 1